AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04946526 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Broccoli seed extract with mustard seed powder
Description: 2 capsules, one dose
Study NCT04736095 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: 3D Ultrasound
Description: Doing 3D ultrasound for diagnosis of submucous myoma
Study NCT04736095 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hysteroscopy
Description: Doing hysteroscopy for diagnosis of submucous myoma
Study NCT05594329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instant noodle soup containing containing the equivalent of 2 servings (18.78g) of powdered Pleurotus oyster mushroom.
Description: Ingredients: celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, dried Pleurotus oyster mushroom, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
Study NCT05594329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instant noodle soup containing containing the equivalent of 1 serving (9.39g) of powdered Pleurotus oyster mushroom.
Description: Ingredients: cornflour, celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, dried Pleurotus oyster mushroom, maltodextrin, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
Study NCT05594329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instant noodle soup containing containing the equivalent of 0.5 serving (4.70g) of powdered Pleurotus oyster mushroom.
Description: Ingredients: cornflour, celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, dried Pleurotus oyster mushroom, maltodextrin, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
Study NCT05594329 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Control instant noodle soup
Description: Ingredients: cornflour, celery, garlic, ginger, gluten, polyphosphate, parsley, pepper, potassium carbonates, maltodextrin, salt, sodium, sunflower oil, turmeric, yeast extract and wheat flour.
Study NCT05094180 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Face-to-face appointment
Description: Participants will be scheduled with face-to-face appointments as usual (control arm). All phone calls (except reminders for scheduled visits) performed by the physician during the study will be recorded. Per protocol, participants allocated in the control arm can receive up to 25% of physician-doctor interactions by phone (that is, one phone call allowed for three face-to-face appointments).
Study NCT05094180 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Remote consultation (telephone or video consultation mode)
Description: Patients will be seen through one of the two remote consultation modalities: video consultation or telephone. Patients will receive a reminder by text or call before the appointment.~In the case of telephone consultation, patients will be informed of the date and time slot in which they must wait for the doctor's call. At the time of the appointment, the doctor will call the contact phone number of the patients and/or their family members, starting with the first contact number that appears in the patient's medical history, and using the rest of the contacts available if there is no response. .~In the case of video consultation, at the time of the appointment, patients will receive a link to the application that manages the teleconsultation. Once in the application, they will remain in the virtual waiting room until the doctor switches to the videoconference.
Study NCT06299735 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally Invasive Cardiac Surgery (airway management with double-lumen tube)
Description: Anesthesia induction will involve 1 mg/kg lidocaine, 1 µg/kg fentanyl, 1 mg/kg propofol, and 0.7 mg/kg rocuronium. Following anesthesia induction, a double-lumen tube will be inserted.Subsequently, patients will be connected to a mechanical ventilator. Tube placement will be confirmed using fiberoptic bronchoscopy.
Study NCT06299735 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Minimally Invasive Cardiac Surgery (airway management with endobronchial blocker)
Description: Anesthesia induction will involve 1 mg/kg lidocaine, 1 µg/kg fentanyl, 1 mg/kg propofol, and 0.7 mg/kg rocuronium. Following anesthesia induction, endotracheal tube-bronchial blocker will be inserted.Subsequently, patients will be connected to a mechanical ventilator. Tube placement will be confirmed using fiberoptic bronchoscopy.
Study NCT06308900 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical simulation
Description: Carrying out a total of 9 clinical simulation in three days, one day a week, where the student resolves a situation by taking on the role of a physiotherapist with a simulated patient.
Study NCT05308394 — intervention group
Intervention type: OTHER
Intervention: No experimental intervention will take place - the study is cross-sectional. Each participant will provide biological samples.
Description: Each participant will provide a blood and fecal sample.
Study NCT04121806 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: UC intervention diet
Description: The treatment diet has been designed based on the literature with the goal of influencing the biodiversity and density of the microbiome. All food through the duration of the 8 week dietary intervention period of the study will be provided to the treatment arm study participants.
Study NCT05925153 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04799158 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vonoprazan
Description: Orally via capsules
Study NCT04799158 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Orally via capsules
Study NCT05833841 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Surface Electromyography and Video fluoroscopy
Description: Surface EMG of three muscle groups (masseter, submental, and infrahyoid) and video fluoroscopy with Omnipaque
Study NCT04040465 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aspirin
Description: Participants will be categorized into 3 BMI groups and will be randomly given various doses of aspirin to compare effectiveness and create a dosing regimen.
Study NCT03674775 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: DART QI Program Participation
Description: Antibiotic prescribing data will be collected at multiple time points both before and after the initiation of the intervention.
Study NCT04962035 — intervention group
Intervention type: OTHER
Intervention: Neurocognitive Follow-up
Description: Standard clinical and parent-reported outcomes on cognitive development, temperament and overall health conditions.
Study NCT05435950 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sono-Intruments
Description: Spirecut's single use, pre-CE Sono-Instruments (SI) allow the percutaneous treatment of Carpal Tunnel (CT) syndrome and Trigger Finger/thumb (TF) under sonography (instead of open or endoscopic approach).~Two models will be assessed:~* The Carpal Tunnel Sono-Instrument® (CT-SI), for CT syndrome release, by progressively cutting the transverse carpal ligament.~* The Trigger Finger Sono-Instrument® (TF-SI), for TF release by progressively cutting the A1 annual pulley.
Study NCT06405763 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Snodgrass repair
Description: A relaxing incision is made in the midline by using scalpel or scissors~A 6 F stent is passed into the bladder. The neourethra is closed
Study NCT06405763 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Snodgrass repair with graft
Description: A relaxing incision is made in the midline by using scalpel or scissors In grafted Snodgrass repairA free graft was measured and harvested from the inner prepuce and was defatted and sutured onto the incised urethral plate The graft was sutured overlying the incision line A 6 F stent is passed into the bladder. The neourethra is closed
Study NCT06375486 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivonescimab（AK112，a PD-1/VEGF bispecific antibody）
Description: All enrolled subjects will receive Ivonescimab（AK112，a PD-1/VEGF bispecific antibody，20mg/kg Q3W) in combination with HAIC (utilizing the FOLFOX chemotherapy regimen)
Study NCT05422183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab
Description: 400mg，sc，d1，Q3W
Study NCT05422183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: 8 mg(BW\<60 kg) OR 12 mg(BW≥60 kg)，po，qd，d1-21，Q3W
Study NCT05422183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VP-16
Description: 50 mg/d, po,d1-14，Q3W
Study NCT06064955 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer Support
Description: Former caregivers will be paired with a current caregiver based on a similar personal attribute (e.g., relationship to care recipient). Each pair will complete at least five virtual face-to-face (video) interactions and at least 10 other interactions either via phone call, email, or text messaging over the 6-month time period.
Study NCT04964856 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ERAS exercise
Description: Take ERAS exercise twice a day from hospitalization to 30 days after surgery
Study NCT04964856 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: No ERAS exercise
Description: Don't take ERAS exercise in perioperative period
Study NCT05410093 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Resveratrol
Description: Take Resveratrol (250mg, NuMedica, FDA approved) at a dose of 250mg per day for three months
Study NCT05410093 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin E
Description: Take vitamin E at a dose of 100 mg per day for three months
Study NCT06470477 — intervention group
Intervention type: DRUG
Intervention: Guideline-based treatment
Description: Guideline-based treatment includes anti-platelet therapy, control of vascular risk factors, and so on.
Study NCT06052527 — intervention group
Intervention type: OTHER
Intervention: Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
Description: A novel treatment recommendation system for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza, which is based on machine learning
Study NCT05976776 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: The Childbirth and Parenthood Preparation Education
Description: The Childbirth and Parenthood Preparation Education program will be applied to the experimental group for a period of 1 month (each week, once a week in total four sessions).
Study NCT04765917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Selected physical Therapy program
Description: -Facilitation of balance reactions from standing position including: Standing on one leg, weight shifting from standing position, stoop and recover from standing, squat from standing, standing on balance board and pushing the child in different directions.~* Facilitation of counterpoising mechanism through instructing the child to kick ball from standing position as well as catching and throwing ball with his hands.~* Strengthening exercises for weakened muscles in upper and lower limbs muscle.~* Strengthening exercises for back and abdominal muscles.~* Stretching exercises for tight muscles in upper and lower limbs.~* Gait training activities for correction of gait pattern including: walking on balance beam, walking on balance board, walking on uneven surface, walking using different obstacles (rolls, wedges, stepper) and walking up and down stairs.~* Jumping in place and jumping a board.
Study NCT04765917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Selected physical Therapy program
Description: -Facilitation of balance reactions from standing position including: Standing on one leg, weight shifting from standing position, stoop and recover from standing, squat from standing, standing on balance board and pushing the child in different directions.~* Facilitation of counterpoising mechanism through instructing the child to kick ball from standing position as well as catching and throwing ball with his hands.~* Strengthening exercises for weakened muscles in upper and lower limbs muscle.~* Strengthening exercises for back and abdominal muscles.~* Stretching exercises for tight muscles in upper and lower limbs.~* Gait training activities for correction of gait pattern including: walking on balance beam, walking on balance board, walking on uneven surface, walking using different obstacles (rolls, wedges, stepper) and walking up and down stairs.~* Jumping in place and jumping a board.
Study NCT04765917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Motor imagery training program
Description: As a preparation each child will be shown a video of 5 minutes of normal movements.~They will be positioned in a comfortable position. The screen is in the child's visual field. Children will be asked to close their eyes and imagine they will perform the physically practiced task for 10 minutes, similar to one shown in the video. Sequence of the task will be verbally explained to the child for better recalling of sensations in muscles during the movements. During the entire exercise schedule child's attention will be focused on the position, and movement of their body, on proprioceptive inputs coming from the leg muscles and on the tactile sensations of foot floor contact.~Thereafter, the child will be asked to perform the sequence of tasks, rehearsed mentally for 20 minutes.
Study NCT06220487 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prednisone, Olverembatinib, Blinatumomab, Chidamide
Description: Phase One. Induction Consolidation, for 1 year. 1.1 Pretreatment ×1 cycle. Prednisone，1mg/kg/d, from day 1 to 14;~1.2 Induction Therapy × 1 cycle. A: OlverembAtinib (at a dose of 40 mg Qod), from day 8 to 42. B: Blinatumomab (at a dose of 28 μg per day), from day 15 to 28. C: Chidamide (at a dose of 10 mg Qod), from day 9 to 41.~1.3 Consolidation Block × 5 cycles. A: Olverembatinib (at a dose of 40 mg Qod) was administered from day 1 to 42. B: Blinatumomab (at a dose of 28 μg perday) was administered from day 1 to 14. C: Chidamide (at a dose of 10 mg Qod) was administered from day 14 to 41.~Phase Two. Maintenance Therapy, for 3 years. 2.1 A: Olverembatinib (at a dose of 40 mg Qod) was administered from day 1 to 42.~C: Chidamide (at a dose of 10 mg Qod) was administered from day 14 to 41.~Phase Three. Follow-up, for 5 years.
Study NCT06435546 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood samples
Description: Ferritin, Transferrin Saturation (TSAT), Serum iron, Haemoglobin, Albumin
Study NCT06435546 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Adherence to anti-cancer therapies questionnaires
Description: GIRERD questionnaire, AdOT questionnaire, Use of social networks and alternatives and complementary medicines using patient questionnaire, EORTC QLQC30, HADS, MNA, MSPSS
Study NCT05137002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CIN-107
Description: CIN-107 tablets by mouth once daily
Study NCT05137002 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablets by mouth once daily
Study NCT06485622 — intervention group
Intervention type: PROCEDURE
Intervention: open bypass group
Description: After heparinization, the target artery is clamped above and below the anastomosis. The target artery is dissected along the anterior wall, calcium portions or mural thrombus are removed. Graft (autologous or prosthetic graft) is cut obliquely and anastomosis suturing starts with distal angle. Next stage is tunnel creating for graft conduction.
Study NCT06485622 — intervention group
Intervention type: PROCEDURE
Intervention: bare metal stent group
Description: Bare metal stent implantation during the index procedure.
Study NCT06485622 — intervention group
Intervention type: PROCEDURE
Intervention: plain old balloon angioplasty group
Description: Only plain old balloon was used during the index procedure.
Study NCT06485622 — intervention group
Intervention type: PROCEDURE
Intervention: drug-coated balloon group
Description: Drug-coated balloon was used during the index procedure.
Study NCT06485622 — intervention group
Intervention type: PROCEDURE
Intervention: directional atherectomy group
Description: Directional atherectomy (with or without drug-coated balloon) during the index procedure.
Study NCT06485622 — intervention group
Intervention type: PROCEDURE
Intervention: hybrid repair group
Description: Femoral artery arteriotomy. Further execute a direct endarterectomy femoral artery and from the mouth of a hip artery. Arteriotomy of the femoral artery is closed with a vascular patch use (synthetic or biological). Endovascular revascularization followed.
Study NCT03667443 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Myo-inositol + folic a. + α-lactalbumin
Description: 3 months of treatment
Study NCT03667443 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Myo-inositol + folic a.
Description: 3 months of treatment
Study NCT05309330 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: This is a non-interventional study.
Study NCT04805164 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Corticotomy and use of the bone substitute : Cerament-G device.
Description: Corticotomy and Cerament-G device
Study NCT04805164 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Corticotomy
Description: Corticotomy
Study NCT06376760 — intervention group
Intervention type: OTHER
Intervention: No interventions, it is a observational study
Description: No interventions, this study is to compare the dosage requirement of intravenous anesthetic drug during digestive endoscopy between insomnia group and normal sleep group.
Study NCT04014244 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Corticosteroid vs. Dextrose
Description: US guided injection of corticosteroid in one hand and 5% glucose in the other will be performed in accordance with randomization. In a syringe both substances will be diluted using 0.9% NaCl to a total injection volume of 6 ml. In-plane ulnar approach will be used to visualize the median nerve at the level of the pisiform bone. A standard 23 gauge needle will be inserted in the carpal tunnel with the needle tip positioned between retinaculum and median nerve.
Study NCT04014244 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Corticosteroid or Dextrose vs. Surgery
Description: Injection will be performed unilaterally, after randomization of sides, by the same examiner as in the first part of the study. In all patients included in the second part of the study surgical release will be performed by the same plastic surgeon. The procedure will be performed under local anesthesia, following the same standard protocol. Both treatments will be performed maximally 2 months after diagnosis, with maximum period between them of 1 week.
Study NCT04866381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-6390
Description: SHR-6390
Study NCT04866381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-6390 + Camrelizumab (SHR-1210)
Description: SHR-6390 combined with Camrelizumab (SHR-1210)
Study NCT04866381 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab (SHR-1210) + SHR-1020
Description: Camrelizumab (SHR-1210) combined with SHR-1020
Study NCT05263648 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Virtual Reality Session
Description: VR-based education sessions will be used to influence patients' perceived emotional and social distress while undergoing radiation therapy (RT).~Emotional and social distress levels will be evaluated using questionnaires at baseline (prior to the first VR experience), at completion of RT, and at 30-60 days post RT.
Study NCT06344468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Early Mobilization
Description: Essentially, early mobilization practices consist of two parts: in-bed and out-of-bed. In-bed mobilization; Active-passive joint range of motion (ROM) Exercises include raising the head in bed, turning in bed, in-bed exercises and sitting at the end of the bed. Out-of-bed mobilization includes the process of transferring from bed to chair, standing up, and returning to bed after standing up. In studies conducted on cardiac surgery, the early mobilization period is the first 12 hours.
Study NCT06109558 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LMV-12(HE003)
Description: 1 cycle was 28 days. LMV-12(HE003), 30mg or 60mg, continuously for 21 days, and the drug was discontinued for 7 days. Osimertinib, 80mg, continuously for 28 days.
Study NCT06524167 — intervention group
Intervention type: RADIATION
Intervention: adjuvant radiotherapy
Description: The patients would receive external radiation therapy within 6 weeks after surgery, using intensity-modulated radiation therapy (IMRT) or volume modulated radiation therapy (VMAT) techniques. 6MV-X-ray irradiation. Conventional segmented irradiation is used, once a day, five times a week, with a segmented dose of 2Gy per dose.
Study NCT05664256 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Build capacity of canteen
Description: The investigators will conduct 1 day orientation training to the school nurse, principal and canteen managers of the facilities.~Different sessions on basic nutrition concept, healthy eating, healthy cooking practices including purchasing and serving will be conducted.~The investigators will develop training manuals: training curriculum, facilitators guide, and participants guide, aligning with policy contents.
Study NCT05664256 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Information, Education and Communication materials
Description: Posters showing healthy plate model will be displayed on the canteen walls. The fact sheet on healthy eating will be distributed to all the public facilities and make it available at the entrance/ gate of the canteen.
Study NCT05664256 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Monitoring visit
Description: A monitoring team from each municipality will be formed. The monitoring plan will be prepared with the team. At least one monitoring visit from the municipality government with onsite feedback will be done.